Volume 5, Issue 4 (2019)                   Pharm Biomed Res 2019, 5(4): 1-20 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fasili Z, Mehri F, Ebrahimi H A, Jamali Z, Mohammad Khanlou E, Kahrizi F et al . Applying Nanoparticles in the Treatment of Viral Infections and Toxicological Considerations. Pharm Biomed Res. 2019; 5 (4) :1-20
URL: http://pbr.mazums.ac.ir/article-1-247-en.html
1- Nutrition Health Research Center, Food and Drug Control Laboratory, Hamadan University of Medical Sciences, Hamadan, Iran.
2- Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
3- Department of Pharmaceutics, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran, Department of Addiction Studies, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
4- Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
Abstract:   (1563 Views)
Background: Despite the tremendous progress in human medicine, viral infections can cause death in them. Due to the high prevalence of viruses, it is required to develop novel treatment strategies and provide the site-specific delivery of antiviral agents at the viral reservoirs.
Objectives: Particle size is a vital physical characteristic that can affect the bioavailability and circulation time of nanoparticles. The ratio of large surface area and volume of nanoparticle could enhance the solubility of poorly soluble drug compounds. 
Methods: Therefore, the optimum surface charge of the nanoparticle with the possibility of encapsulation and large drug cargo, are some of the nanoformulation advantages of these agents.
Results: This study reviewed various nanocarriers and modern smart delivery technologies, such as liposomes and immunoliposomes, polymeric nanoparticles, nanoemulsions, nanosuspensions, dendrimers, solid lipid nanoparticles, and so on.
Conclusion: We aimed to overcome the problems of traditional formulations and resistance to currently available therapies in various infections. Moreover, the concerns about the potential toxicities of nanoparticles to humans have been raised; therefore, the present study has reviewed the toxicity effects of nanoparticles used in controlling viral infections. 
Full-Text [PDF 2640 kb]   (176 Downloads)    
Type of Study: Research | Subject: Nanotechnology

Add your comments about this article : Your username or Email:
CAPTCHA

© 2020 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb